Navigation
About Us
Overview
Management Team
Board of Directors
Scientific Advisory Board
Pipeline
Overview
Ampion
About Osteoarthritis
Optina
About Diabetic Macular Edema
Partnering
Investors
Stock Information
Financial Filings
Corporate Governance
Presentations & Media
News
Latest News
Publications
Contact Us
About Us
Overview
Management Team
Board of Directors
Scientific Advisory Board
Pipeline
Overview
Ampion
About Osteoarthritis
Optina
About Diabetic Macular Edema
Partnering
Investors
Stock Information
Financial Filings
Corporate Governance
Presentations & Media
News
Latest News
Publications
Contact Us
Ampio Pharmaceuticals
Ampio Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options. We are developing compounds that serve significant medical needs in osteoarthritis, diabetic macular edema, and other prevalent, inflammatory diseases through an innovative discovery and development platform.
Ampion™
Ampion™
 for the treatment of pain due to osteoarthritis of the knee.
Learn About Ampion
Optina™
Optina™
 for the treatment of Diabetic Macular Edema.
Learn About Optina
Real Time Quote
 Latest News 
Ampio Updates Regulatory and Publication status for Ampion™
November 26, 2018
Ampio Updates Regulatory and Clinical Status for Ampion™
November 7, 2018
Ampio Provides Corporate Update
October 4, 2018
© 2018 Ampio Pharmaceuticals Inc.
373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA
Privacy Policy
Main office: +1 720 437 6500
Fax: +1 720 437 6501
General email inquiries: 
info@ampiopharma.com
Home
About Us
Pipeline
Partnering
Investors
News
Contact Us